Vellinga, A.; Luke-Currier, A.; Garzón-Orjuela, N.; Aabenhus, R.; Anastasaki, M.; Balan, A.; Böhmer, F.; Lang, V.B.; Chlabicz, S.; Coenen, S.;
et al. Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries. Antibiotics 2023, 12, 572.
https://doi.org/10.3390/antibiotics12030572
AMA Style
Vellinga A, Luke-Currier A, Garzón-Orjuela N, Aabenhus R, Anastasaki M, Balan A, Böhmer F, Lang VB, Chlabicz S, Coenen S,
et al. Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries. Antibiotics. 2023; 12(3):572.
https://doi.org/10.3390/antibiotics12030572
Chicago/Turabian Style
Vellinga, Akke, Addiena Luke-Currier, Nathaly Garzón-Orjuela, Rune Aabenhus, Marilena Anastasaki, Anca Balan, Femke Böhmer, Valerija Bralić Lang, Slawomir Chlabicz, Samuel Coenen,
and et al. 2023. "Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries" Antibiotics 12, no. 3: 572.
https://doi.org/10.3390/antibiotics12030572
APA Style
Vellinga, A., Luke-Currier, A., Garzón-Orjuela, N., Aabenhus, R., Anastasaki, M., Balan, A., Böhmer, F., Lang, V. B., Chlabicz, S., Coenen, S., GarcÃa-SangenÃs, A., Kowalczyk, A., Malania, L., Tomacinschii, A., van der Linde, S. R., Bongard, E., Butler, C. C., Goossens, H., & van der Velden, A. W.
(2023). Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries. Antibiotics, 12(3), 572.
https://doi.org/10.3390/antibiotics12030572
